Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Bob Olsson
Based on 14 articles published since 2010
(Why 14 articles?)
||||
Expertise Level
The expertise of Bob Olsson ranks in the
  • Top 0.92%
  • ... of 138,462 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Goteborg University      
2019
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Department of Molecular Neuroscience, UCL Queen Square Institute of Neurology, London, United Kingdom. · United Kingdom Dementia Research Institute, London, United Kingdom. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia. · Parkinson's Disease Research, Education and Cinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania. · Mental Illness Research, Education and Cinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia. · Department of Neurology, Houston Methodist Hospital, Houston, Texas. · Pubmed 30508027
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; UK Dementia Research Institute, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Neurology, University Medical Centre, Ljubljana, Slovenia. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Department of Neurology, Houston Methodist Hospital, Houston, TX, USA. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA. · Fujirebio Europe nv, Ghent, Belgium. · Pubmed 30321501
2018
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1E 6BT, UK. · UK Dementia Research Institute, London, WC1E 6BT, UK. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA. · Department of Neurology, Houston Methodist Hospital, Houston, TX, USA. · Pubmed 29700597
2017
  • a Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry , The Sahlgrenska Academy at the University of Gothenburg , Mölndal , Sweden. · b Dementia Research Centre, Institute of Neurology , University College London , London , UK. · c Clinical Neurochemistry Laboratory , Sahlgrenska University Hospital , Mölndal , Sweden. · d Department of Molecular Neuroscience , UCL Institute of Neurology, Queen Square , London , United Kingdom. · e UK Dementia Research Institute , London , UK ​​​. · Pubmed 28604243
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. · Department of Veterans Affairs Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, CA, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Department of Neurology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland. · AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Memory Clinic, Skåne University Hospital, Malmö, Sweden. · Department of Neurology, Skåne University Hospital, Lund, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. · Pubmed 29061195
2016
  • Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Biomedical Sciences, University of Antwerp, Belgium. · Department of Radiation Physics, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Alzforum, Cambridge, MA, USA. · Unit for Health Metrics, Department of Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Pubmed 27068280
2015
  • Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden3University College London Institute of Neurology, Queen Square, London, England. · Pubmed 26258692
2014
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden3Memory Clinic, Skåne University Hospital, Malmö, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden4Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical C. · Department of Neurology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland. · GE Healthcare, Life Sciences, Uppsala, Sweden. · Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Université Pierre et Marie Curie, Paris, France. · Department of Psychiatry, University of Halle, Halle, Germany. · Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical Center, San Francisco, California. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden9Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sw. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden10Institute of Neurology, University College of London, London, England. · Pubmed 25162367
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. Electronic address: · Service d'Hématologie Clinique, Hôpital de l'Archet, Nice, France. · INSERM CIC 0802, CHU de Poitiers, Poitiers, France. · AstraZeneca R&D, Södertälje, Sweden. · Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Quanterix Corporation, Cambridge, MA, USA. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, UK. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 24331439
2013
  • Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 23254629
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 22890100
2012
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Pubmed 22785399
2011
  • Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, S-431 80 Mölndal, Sweden. · Pubmed 21567187
Possible:    Linkoping University      
2014
  • Experimental Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden, · Pubmed 24101586
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Bob Olsson about Alzheimer Disease:

  • Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. 2019
  • Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. 2019
  • Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. 2018
  • The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials. 2017
  • Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations. 2017
  • CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. 2016
  • Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease. 2015
  • Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. 2014
  • Imatinib treatment and Aβ42 in humans. 2014
  • Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease. 2014
Show List of Full Article Records
Google Searches

Learn more about Bob Olsson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Goteborg University
Linkoping University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Goteborg University
2019
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Department of Molecular Neuroscience, UCL Queen Square Institute of Neurology, London, United Kingdom. · United Kingdom Dementia Research Institute, London, United Kingdom. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia. · Parkinson's Disease Research, Education and Cinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania. · Mental Illness Research, Education and Cinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia. · Department of Neurology, Houston Methodist Hospital, Houston, Texas. · Pubmed 30508027
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; UK Dementia Research Institute, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Neurology, University Medical Centre, Ljubljana, Slovenia. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Department of Neurology, Houston Methodist Hospital, Houston, TX, USA. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA. · Fujirebio Europe nv, Ghent, Belgium. · Pubmed 30321501
2018
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1E 6BT, UK. · UK Dementia Research Institute, London, WC1E 6BT, UK. · Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA. · Department of Neurology, Houston Methodist Hospital, Houston, TX, USA. · Pubmed 29700597
2017
  • a Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry , The Sahlgrenska Academy at the University of Gothenburg , Mölndal , Sweden. · b Dementia Research Centre, Institute of Neurology , University College London , London , UK. · c Clinical Neurochemistry Laboratory , Sahlgrenska University Hospital , Mölndal , Sweden. · d Department of Molecular Neuroscience , UCL Institute of Neurology, Queen Square , London , United Kingdom. · e UK Dementia Research Institute , London , UK ​​​. · Pubmed 28604243
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. · Department of Veterans Affairs Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, CA, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Department of Neurology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland. · AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Memory Clinic, Skåne University Hospital, Malmö, Sweden. · Department of Neurology, Skåne University Hospital, Lund, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. · Pubmed 29061195
2016
  • Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Biomedical Sciences, University of Antwerp, Belgium. · Department of Radiation Physics, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Alzforum, Cambridge, MA, USA. · Unit for Health Metrics, Department of Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Pubmed 27068280
2015
  • Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden3University College London Institute of Neurology, Queen Square, London, England. · Pubmed 26258692
2014
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden3Memory Clinic, Skåne University Hospital, Malmö, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden4Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical C. · Department of Neurology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland. · GE Healthcare, Life Sciences, Uppsala, Sweden. · Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Université Pierre et Marie Curie, Paris, France. · Department of Psychiatry, University of Halle, Halle, Germany. · Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs Medical Center, San Francisco, California. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden9Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sw. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden10Institute of Neurology, University College of London, London, England. · Pubmed 25162367
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. Electronic address: · Service d'Hématologie Clinique, Hôpital de l'Archet, Nice, France. · INSERM CIC 0802, CHU de Poitiers, Poitiers, France. · AstraZeneca R&D, Södertälje, Sweden. · Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Quanterix Corporation, Cambridge, MA, USA. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, UK. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 24331439
2013
  • Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 23254629
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. · Pubmed 22890100
2012
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Pubmed 22785399
2011
  • Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, S-431 80 Mölndal, Sweden. · Pubmed 21567187
Linkoping University
2014
  • Experimental Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden, · Pubmed 24101586
Yearly article counts 02121132110
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.